Navigation Links


Kidney at medicine technology

Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free Survival by 45 Percent in Patients With Intermediate-Risk Kidney Cancer

ANAHEIM, Calif.--(BUSINESS WIRE)--May 21, 2007 - Antigenics Inc.(NASDAQ: AGEN) today announced additional follow-up data on thecompany's Phase 3 investigational therapeutic cancer vaccineOncophage(R) (vitespen). The end-of-study results, which reflect anadditional 17 months' data collection, showed that in a substantialsubset of patients (n = 362) at intermediate risk for diseaserecurrence,...

Early Results of the CellCept Spare the Nephron Study Examine Kidney Function

SAN FRANCISCO, May 07, 2007 /PRNewswire/ -- Interim results froma multicenter trial investigating a novel kidney-sparing treatmentprotocol using CellCept(R) (mycophenolate mofetil) were presentedat the American Transplant Congress. This and other Spare theNephron (STN) trials in kidney and liver transplant recipientsexamine ways to prevent rejection without damaging kidneys. As tra...

Isotechnika Announces Interim Three Month Data from Phase 2b Kidney Transplant Trial

EDMONTON, May 07, 2007 /PRNewswire-FirstCall/ - Isotechnika Inc.today announced the audited three month results, reviewed by theData Monitoring Committee, of the first third of the patientstreated in its Phase 2b de novo kidney transplant trial for theCompany's lead immunosuppressive drug, ISA247. This interim analysis is based upon the assessment of the first116 patients enrolled....

Mircera Effective in Stabilising Haemoglobin Levels in Elderly Patients With Kidney Disease on Dialysis

Findings Illustrate Role of Innovative New Treatment in PopulationMost Affected by Chronic Kidney Disease BASEL, Switzerland, April 23, 2007 /PRNewswire/ -- A new RochePhase III analysis shows once-monthly MIRCERA, a continuouserythropoietin receptor activator, effectively treats renal anaemiain one of the fastest growing groups of patients with chronickidney disease (CKD) -- elderly pati...

Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month Hematide for the Treatment of Anemia in Patients with Early- and End-Stage Chronic Kidney Disease

PALO ALTO, Calif.--(BUSINESS WIRE)--Apr 23, 2007 - Affymax, Inc.(Nasdaq:AFFY) today announced results to date from two separatePhase 2 clinical trials of Hematide(TM) in dialysis andnon-dialysis chronic kidney disease (CKD) patients. The data showedthat in treatment naive, non-dialysis patients Hematide couldcorrect anemia when administered monthly at an appropriate dose.Similarly, the data...

Genzyme Announces Successful Completion of Study Investigating Sevelamer Carbonate in Patients With Chronic Kidney Disease

CAMBRIDGE, Mass., April 16, 2007 /PRNewswire-FirstCall/ --Genzyme Corp. announced today that a recently completed study ofRenvela(TM) (sevelamer carbonate) achieved its primary endpoint,demonstrating a statistically significant reduction in serumphosphorus for hyperphosphatemic patients with chronic kidneydisease who are not on dialysis. Patients treated with Renvela also achieved...

Data Analyses Outline Efficacy and Safety of Mircera for the Treatment of Renal Anemia Associated With Chronic Kidney Disease

ORLANDO, Fla. and NUTLEY, N.J., April 12, 2007/PRNewswire-FirstCall/ -- Data analyses from the largest initialregistration clinical trial program ever undertaken in the renalanemia arena provide efficacy and safety information on theinvestigational anemia therapy MIRCERA(TM) for the treatment ofrenal anemia associated with chronic kidney disease (CKD) inpatients on dialysis and not on di...

Isotechnika's independent data monitoring committee conducts review of phase 2b kidney transplant trial

- Company Set to Host Evening Symposium at ATC - EDMONTON, March 27 /CNW/ - Isotechnika Inc. announced today thatan independent data monitoring committee (DMC) has met and reviewedthe interim data from the Phase 2b kidney transplant (PROMISE)trial. The review included 3 month data from approximately 1/3 ofthe anticipated 332 patients to be enrolled. The DMC hasrecommended that...

Nearly 1 in 10 Americans Has A Relative With Kidney Failure

African-Americans with Family History of ESRD Are at HighRisk WASHINGTON, March 9, 2007 - Approximately ten percent of U.S.adults have a family history of end-stage renal disease (ESRD), andthese individuals appear to be at increased risk of developingkidney disease themselves, reports a study in the April Journal ofthe American Society of Nephrology. "A family histo...

Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings

CAMBRIDGE, Mass., March 06, 2007 /PRNewswire-FirstCall/ --Advanced Magnetics today announced that data from three completedPhase III multi- center clinical studies of ferumoxytol as anintravenous iron replacement therapeutic will be presented duringthe National Kidney Foundation (NKF) 2007 Spring Clinical Meetingstaking place April 10th through 14th in Orlando, Florida. Twoposters contai...
Other TagsarmingarmingarmingarmingNSWNSWNSWintintintintintintintintintCRPObesitObesitObesitPonePonePonePone
(Date:7/24/2008)...team led by Massachusetts General Hospital (MGH) i... genomic research and medicine a robust method fo...ticular DNA sequences for inactivation or repair. ...searchers describe an efficient, publicly availabl...ses (ZFNs), which can be used to induce specific g...
(Date:7/24/2008)...a telescope promise to make it easier for people w...es requiring sharper distance vision. Schepens Eye...ages of these innovative glasses over earlier devi...of Journal of Biomedical Optics , mailed in prin...esign has several advantages," says the inventor o...
(Date:7/24/2008)...y 24, 2008 Adult stem cells originate in a differ...nd with proper stimulation they can produce new br...ry, a study by UC Irvine scientists has shown. , ...in the mammalian brain are the ependymal cells tha..., rather than cells in the subventricular zone as ...
(Date:7/24/2008)...ientists at Harvard University and the University ...on is strongly shaped by genes, efforts to prevent...ir study also suggests that the cost of errors in ...ns themselves, rather than the loss of functional ...lived cells, like neurons, and cause neurodegenera...
Breaking Biology News(10 mins):Consortium develops new method enabling routine targeted gene modification 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 3Adult stem cells activated in mammalian brain 2Adult stem cells activated in mammalian brain 3Various species' genes evolve to minimize protein production errors 2Various species' genes evolve to minimize protein production errors 3APIC Statement on Need for Increased Prevention Measures for Healthcare Associated Infections 28HAIs 29 3262 1APIC Statement on Need for Increased Prevention Measures for Healthcare Associated Infections 28HAIs 29 3262 2Launch of New Prestigious Infertility and Gynaecology Research GrAnt 28FRIGGA 29 3261 1Launch of New Prestigious Infertility and Gynaecology Research GrAnt 28FRIGGA 29 3261 2Kiplingers Long Term Care Consumer Video Sponsored by John Hancock Life Insurance Company Wins National Aegis Award 11802 1Kiplingers Long Term Care Consumer Video Sponsored by John Hancock Life Insurance Company Wins National Aegis Award 11802 2Kiplingers Long Term Care Consumer Video Sponsored by John Hancock Life Insurance Company Wins National Aegis Award 11802 3DNA with a twist 3A New company to search for cancer drugs and antibiotics 11798 1DNA with a twist 3A New company to search for cancer drugs and antibiotics 11798 2
(Date:7/25/2008)...ON, July 25 /PRNewswire/ -- The Elekta Family of C... treatment solutions at the 2008,American Associat...g,demonstrating how the joint forces of Elekta, I... therapy planning and delivery solutions that,stre...perience for,patients, as well as enhance clinicia...
(Date:7/25/2008)...ds fluid back-up in esophagus can cause immune sys...ay News) -- The first evidence linking gastroesoph...scovered by Duke University Medical Center researc...ns was first noted in the 1970s, and since then st...rcent of asthma patients also experience GERD symp...
(Date:7/25/2008)... The Retina Group of New York will...ted macular degeneration especially designed for s...e Public Library at 116 Merritts Road, Farmingdale.... Attendance is free and refreshments will be prov...6) 939-6100. , Hicksville...
(Date:7/25/2008)... This donation will be used to fac...ve services for children , ... ( www.ivci.com ), a leading integrator of enterp...tion video conferencing, telepresence, audio visua...announced today that it has donated video conferen...
Breaking Medicine News(10 mins):Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:People With GERD More Likely to Develop Asthma 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2
Other Contentssymbiosissymbiosissubstratesubstratesubstratesubstratesubstratesubstratesubstratesubstratesynapsesynapsesynapsesynapsesynapsesystemssystemssystemssystemssystemssystemssystemssystemssystemssystemstaxonomytaxonomytaxonomycellcellcellcellcellcellcellcellcellcellstructurestructurestructurestructurestructurestructurestructurestructurestructurestructure